$NTRA
Natera, Inc.

2024 Q4 Form 10-Q Financial Statement

#000155837024015325 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $439.8M
YoY Change 63.9%
Cost Of Revenue $168.0M
YoY Change 14.06%
Gross Profit $271.7M
YoY Change 124.58%
Gross Profit Margin 61.79%
Selling, General & Admin $214.2M
YoY Change 38.39%
% of Gross Profit 78.81%
Research & Development $96.93M
YoY Change 25.5%
% of Gross Profit 35.67%
Depreciation & Amortization $8.200M
YoY Change 17.31%
% of Gross Profit 3.02%
Operating Expenses $311.1M
YoY Change 34.1%
Operating Profit -$39.34M
YoY Change -64.55%
Interest Expense $3.142M
YoY Change -3.38%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$30.86M
YoY Change -71.64%
Income Tax $730.0K
% Of Pretax Income
Net Earnings -$31.59M
YoY Change -71.02%
Net Earnings / Revenue -7.18%
Basic Earnings Per Share -$0.26
Diluted Earnings Per Share -$0.26
COMMON SHARES
Basic Shares Outstanding 132.0M 123.7M
Diluted Shares Outstanding 123.8M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $922.3M
YoY Change -1.53%
Cash & Equivalents $892.8M
Short-Term Investments $29.49M
Other Short-Term Assets $44.63M
YoY Change 33.23%
Inventory $48.72M
Prepaid Expenses
Receivables $306.9M
Other Receivables $0.00
Total Short-Term Assets $1.323B
YoY Change 4.36%
LONG-TERM ASSETS
Property, Plant & Equipment $142.2M
YoY Change 35.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $38.36M
YoY Change 136.65%
Total Long-Term Assets $268.4M
YoY Change 49.73%
TOTAL ASSETS
Total Short-Term Assets $1.323B
Total Long-Term Assets $268.4M
Total Assets $1.591B
YoY Change 9.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.83M
YoY Change 30.55%
Accrued Expenses $159.4M
YoY Change 1.62%
Deferred Revenue $17.89M
YoY Change 19.14%
Short-Term Debt $80.47M
YoY Change 0.09%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $301.4M
YoY Change 3.96%
LONG-TERM LIABILITIES
Long-Term Debt $286.5M
YoY Change 1.4%
Other Long-Term Liabilities $124.5M
YoY Change 39.37%
Total Long-Term Liabilities $411.0M
YoY Change 10.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $301.4M
Total Long-Term Liabilities $411.0M
Total Liabilities $712.4M
YoY Change 7.64%
SHAREHOLDERS EQUITY
Retained Earnings -$2.500B
YoY Change 8.7%
Common Stock $3.393B
YoY Change 9.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $878.5M
YoY Change
Total Liabilities & Shareholders Equity $1.591B
YoY Change 9.98%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$31.59M
YoY Change -71.02%
Depreciation, Depletion And Amortization $8.200M
YoY Change 17.31%
Cash From Operating Activities $51.79M
YoY Change -275.25%
INVESTING ACTIVITIES
Capital Expenditures $16.31M
YoY Change 79.25%
Acquisitions
YoY Change
Other Investing Activities $58.85M
YoY Change -34.79%
Cash From Investing Activities $42.54M
YoY Change -47.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.720M
YoY Change -99.27%
NET CHANGE
Cash From Operating Activities 51.79M
Cash From Investing Activities 42.54M
Cash From Financing Activities 1.720M
Net Change In Cash 96.05M
YoY Change -66.61%
FREE CASH FLOW
Cash From Operating Activities $51.79M
Capital Expenditures $16.31M
Free Cash Flow $35.47M
YoY Change -191.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
124137000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
119581000
dei Entity Registrant Name
EntityRegistrantName
Natera, Inc.
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Central Index Key
EntityCentralIndexKey
0001604821
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Shell Company
EntityShellCompany
false
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.14
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
123775000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115171000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
122486000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113559000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y0M7D
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Entity File Number
EntityFileNumber
001-37478
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
01-0894487
dei Entity Address Address Line1
EntityAddressAddressLine1
13011 McCallen Pass
dei Entity Address Address Line2
EntityAddressAddressLine2
Building A Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78753
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
980-9190
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
NTRA
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
132020816
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
892844000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
642095000
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
29490000
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
236882000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6252000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6481000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
306876000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
278289000
CY2024Q3 us-gaap Inventory Net
InventoryNet
48724000
CY2023Q4 us-gaap Inventory Net
InventoryNet
40759000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
44631000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
60524000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
1322565000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1258549000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
142170000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111210000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
87856000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
56537000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38356000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15403000
CY2024Q3 us-gaap Assets
Assets
1590947000
CY2023Q4 us-gaap Assets
Assets
1441699000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
27834000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14998000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
49051000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
45857000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
126176000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
149405000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
17886000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
16612000
CY2024Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
80469000
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
80402000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
301416000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
307274000
CY2024Q3 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
286549000
CY2023Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
282945000
CY2024Q3 ntra Contract With Customer And Other Liabilities Noncurrent
ContractWithCustomerAndOtherLiabilitiesNoncurrent
25504000
CY2023Q4 ntra Contract With Customer And Other Liabilities Noncurrent
ContractWithCustomerAndOtherLiabilitiesNoncurrent
19128000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
98953000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
67025000
CY2024Q3 us-gaap Liabilities
Liabilities
712422000
CY2023Q4 us-gaap Liabilities
Liabilities
676372000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
124137000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119581000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
12000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
11000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3393369000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3145837000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2514091000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2377436000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-765000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3085000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
878525000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
765327000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1590947000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1441699000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
439758000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
268306000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1220850000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
771466000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
96931000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
77235000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
274677000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
237714000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
214154000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
154742000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
606397000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
456877000
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
479096000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
379288000
us-gaap Costs And Expenses
CostsAndExpenses
1378404000
us-gaap Costs And Expenses
CostsAndExpenses
1133175000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-39338000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-110982000
us-gaap Operating Income Loss
OperatingIncomeLoss
-157554000
us-gaap Operating Income Loss
OperatingIncomeLoss
-361709000
CY2024Q3 us-gaap Interest Expense
InterestExpense
3142000
CY2023Q3 us-gaap Interest Expense
InterestExpense
3252000
us-gaap Interest Expense
InterestExpense
9393000
us-gaap Interest Expense
InterestExpense
9490000
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
11618000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
5406000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
32342000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
14509000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30862000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-108828000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-134605000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-356690000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
730000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
202000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2050000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
80000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-31592000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-109030000
us-gaap Net Income Loss
NetIncomeLoss
-136655000
us-gaap Net Income Loss
NetIncomeLoss
-356770000
CY2024Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
593000
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
3807000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2320000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
10966000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30999000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-105223000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-134335000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-345804000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.95
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.14
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123775000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115171000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
122486000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113559000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
836520000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1720000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
71284000
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
593000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-31592000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
878525000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
765327000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10368000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
8862000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
24071000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
204231000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
2320000
us-gaap Net Income Loss
NetIncomeLoss
-136655000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
878525000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
596147000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
562000
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
235441000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
57731000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
3807000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-109030000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
784658000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
705744000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3501000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
8674000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
19771000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
14435000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
235441000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
142896000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
10966000
us-gaap Net Income Loss
NetIncomeLoss
-356770000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
784658000
us-gaap Profit Loss
ProfitLoss
-136655000
us-gaap Profit Loss
ProfitLoss
-356770000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23178000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
17186000
ntra Expensed In Process Research And Development
ExpensedInProcessResearchAndDevelopment
2679000
ntra Premium Amortization And Discount Accretion On Investment Securities
PremiumAmortizationAndDiscountAccretionOnInvestmentSecurities
-633000
ntra Premium Amortization And Discount Accretion On Investment Securities
PremiumAmortizationAndDiscountAccretionOnInvestmentSecurities
1929000
us-gaap Share Based Compensation
ShareBasedCompensation
202502000
us-gaap Share Based Compensation
ShareBasedCompensation
142376000
us-gaap Operating Lease Cost
OperatingLeaseCost
11169000
us-gaap Operating Lease Cost
OperatingLeaseCost
11011000
ntra Noncash Expense Recovery
NoncashExpenseRecovery
80000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
991000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
966000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-356000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-265000
ntra Non Cash Interest Expense
NonCashInterestExpense
2680000
ntra Non Cash Interest Expense
NonCashInterestExpense
85000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
28587000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10762000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7965000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6669000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-13663000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7356000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10841000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8951000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
27265000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
15177000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-12484000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-8424000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-22526000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-2072000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-938000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
5268000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
82777000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-189350000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
122010000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
24822000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
307400000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
173500000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
48305000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29147000
ntra Payments For Investments In Related Party
PaymentsForInvestmentsInRelatedParty
2670000
ntra Payments To Acquire Assets
PaymentsToAcquireAssets
10495000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
148742000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
144353000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10368000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3501000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
8862000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
8674000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
235441000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19230000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
247616000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
250749000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
202619000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
642095000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
466091000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
892844000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
668710000
us-gaap Interest Paid Net
InterestPaidNet
6785000
us-gaap Interest Paid Net
InterestPaidNet
6907000
ntra Purchases Of Property And Equipment In Accounts Payable And Accruals
PurchasesOfPropertyAndEquipmentInAccountsPayableAndAccruals
854000
ntra Purchases Of Property And Equipment In Accounts Payable And Accruals
PurchasesOfPropertyAndEquipmentInAccountsPayableAndAccruals
-1168000
ntra Acquisition Of Warrants And Receivables
AcquisitionOfWarrantsAndReceivables
9424000
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
1400000
us-gaap Stock Issued1
StockIssued1
14435000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
24071000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
19771000
ntra Stock Based Compensation Included In Capitalized Software Development Costs
StockBasedCompensationIncludedInCapitalizedSoftwareDevelopmentCosts
1729000
ntra Stock Based Compensation Included In Capitalized Software Development Costs
StockBasedCompensationIncludedInCapitalizedSoftwareDevelopmentCosts
520000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Net Income Loss
NetIncomeLoss
-136700000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2500000000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
892800000
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
29500000
CY2024Q3 us-gaap Debt Instrument Collateral Amount
DebtInstrumentCollateralAmount
150000000.0
CY2024Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
20000000.0
CY2023Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
400000
CY2023Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
235800000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:12pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:36pt;background:#ffffff;margin:0pt;">The preparation of financial statements in accordance with generally accepted accounting principles (GAAP) in the United States requires management to make estimates and assumptions about future events that affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. Significant items subject to such estimates include the allowance for doubtful accounts, determining the incremental borrowing rate to calculate operating right-of-use assets and the associated lease liabilities, the average useful life for property and equipment including impairment estimates, deferred revenues associated with unsatisfied performance obligations, accrued liability for potential refund requests, stock-based compensation, the fair value of options, income tax uncertainties, and the expected consideration to be received from contracts with customers, insurance payors, and patients. These estimates and assumptions are based on management's best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors, including contractual terms and statutory limits; however, actual results could differ from these estimates and could have an adverse effect on the Company's financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:36pt;background:#ffffff;margin:0pt;"><span style="margin-bottom:5pt;margin-top:5pt;visibility:hidden;">​</span></p>
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1358000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9203000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3085000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16362000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-765000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5396000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-765000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5396000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:12pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Risk and Uncertainties</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:12pt;text-align:justify;text-indent:36pt;background:#ffffff;margin:0pt;">Financial instruments that potentially subject the Company to credit risk consist of cash, cash equivalents, restricted cash, accounts receivable and investments. The Company limits its exposure to loss by placing its cash in financial institutions with high credit ratings. The Company's cash may consist of deposits held with banks that may at times exceed federally insured limits of $250,000 per customer. The Company performs evaluations of the relative credit standing of these financial institutions and limits the amount of credit exposure with any one institution.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:12pt;text-align:justify;text-indent:36pt;background:#ffffff;margin:0pt;">For the three and nine months ended September 30, 2024, and 2023, there were no customers exceeding 10% of total revenues on an individual basis. As of September 30, 2024 and December 31, 2023, there were no customers with an outstanding balance exceeding 10% of net accounts receivable. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:36pt;background:#ffffff;margin:0pt;">For both the three months ended September 30, 2024 and 2023, approximately 12.6% of total revenue were paid by Medicare on behalf of multiple customers. For the nine months ended September 30, 2024 and 2023, approximately 11.5% and 13.0%, respectively, of total revenue were paid by Medicare on behalf of multiple customers. As of September 30, 2024 and December 31, 2023, approximately 10.9% and 10.2%, respectively, of accounts receivable are expected to be paid by Medicare on behalf of multiple customers.</p>
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1300000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
439758000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
268306000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1220850000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
771466000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
439758000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
268306000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1220850000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
771466000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
306876000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
278289000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
17886000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
16612000
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
16916000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
19128000
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
34802000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
35740000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
35740000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
30778000
ntra Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
23968000
ntra Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
24553000
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
-12102000
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
-9610000
us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
-12804000
us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
-9676000
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
34802000
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
36045000
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
-12100000
CY2024Q3 ntra Cash Cash Equivalents Restricted Cash And Securities Amortized Cost Basis
CashCashEquivalentsRestrictedCashAndSecuritiesAmortizedCostBasis
922878000
CY2024Q3 ntra Cash Cash Equivalents Restricted Cash And Securities Accumulated Gross Unrealized Loss
CashCashEquivalentsRestrictedCashAndSecuritiesAccumulatedGrossUnrealizedLoss
544000
CY2024Q3 ntra Cash Cash Equivalents Restricted Cash And Securities
CashCashEquivalentsRestrictedCashAndSecurities
922334000
CY2023Q4 ntra Cash Cash Equivalents Restricted Cash And Securities Amortized Cost Basis
CashCashEquivalentsRestrictedCashAndSecuritiesAmortizedCostBasis
881708000
CY2023Q4 ntra Cash Cash Equivalents Restricted Cash And Securities Accumulated Gross Unrealized Gain
CashCashEquivalentsRestrictedCashAndSecuritiesAccumulatedGrossUnrealizedGain
14000
CY2023Q4 ntra Cash Cash Equivalents Restricted Cash And Securities Accumulated Gross Unrealized Loss
CashCashEquivalentsRestrictedCashAndSecuritiesAccumulatedGrossUnrealizedLoss
2745000
CY2023Q4 ntra Cash Cash Equivalents Restricted Cash And Securities
CashCashEquivalentsRestrictedCashAndSecurities
878977000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
892844000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
642095000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
29490000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
236882000
CY2024Q3 ntra Cash Cash Equivalents Restricted Cash And Securities
CashCashEquivalentsRestrictedCashAndSecurities
922334000
CY2023Q4 ntra Cash Cash Equivalents Restricted Cash And Securities
CashCashEquivalentsRestrictedCashAndSecurities
878977000
ntra Number Of Investments Sold
NumberOfInvestmentsSold
1
CY2024Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
9
CY2024Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2024Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
27990000
CY2024Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
544000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
29034000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
28522000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
1000000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
968000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
30034000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
29490000
CY2024Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
7021000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5580000
CY2024Q3 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
536000
CY2023Q3 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-454000
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
233000
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6252000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6034000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6481000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
3830000
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-208000
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-2204000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
437000
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6252000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6034000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
213298000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
167503000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
71128000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
56293000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
142170000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111210000
us-gaap Depreciation
Depreciation
19900000
us-gaap Depreciation
Depreciation
16100000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2024Q3 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
15778000
CY2023Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
23245000
CY2024Q3 ntra Accrued Charges For Outsourced Testing
AccruedChargesForOutsourcedTesting
9924000
CY2023Q4 ntra Accrued Charges For Outsourced Testing
AccruedChargesForOutsourcedTesting
14823000
CY2024Q3 ntra Accrued Testing And Laboratory Materials From Suppliers
AccruedTestingAndLaboratoryMaterialsFromSuppliers
9823000
CY2023Q4 ntra Accrued Testing And Laboratory Materials From Suppliers
AccruedTestingAndLaboratoryMaterialsFromSuppliers
11229000
CY2024Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
15526000
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
10085000
CY2024Q3 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
36535000
CY2023Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
43897000
CY2024Q3 ntra Accrued Shipping Charges
AccruedShippingCharges
2180000
CY2023Q4 ntra Accrued Shipping Charges
AccruedShippingCharges
3646000
CY2024Q3 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
5061000
CY2023Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
3731000
CY2024Q3 ntra Accrued Specimen Service Fees
AccruedSpecimenServiceFees
8853000
CY2023Q4 ntra Accrued Specimen Service Fees
AccruedSpecimenServiceFees
7111000
CY2024Q3 ntra Accrued Clinical Trials And Studies
AccruedClinicalTrialsAndStudies
7744000
CY2023Q4 ntra Accrued Clinical Trials And Studies
AccruedClinicalTrialsAndStudies
12126000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9762000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11621000
CY2024Q3 ntra Accrued Fixed Asset Purchases
AccruedFixedAssetPurchases
3397000
CY2023Q4 ntra Accrued Fixed Asset Purchases
AccruedFixedAssetPurchases
4316000
CY2024Q3 ntra Accrued Interest
AccruedInterest
1000
CY2023Q4 ntra Accrued Interest
AccruedInterest
1078000
CY2024Q3 ntra Other Accrued Sundry Expenses Current
OtherAccruedSundryExpensesCurrent
1592000
CY2023Q4 ntra Other Accrued Sundry Expenses Current
OtherAccruedSundryExpensesCurrent
2497000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
126176000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
149405000
CY2023Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
23245000
CY2022Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
18948000
ntra Insurance Carrier Reserves Additions
InsuranceCarrierReservesAdditions
1506000
ntra Insurance Carrier Reserves Additions
InsuranceCarrierReservesAdditions
7348000
ntra Insurance Refunds To Carriers
InsuranceRefundsToCarriers
3095000
ntra Insurance Refunds To Carriers
InsuranceRefundsToCarriers
1236000
ntra Insurance Carrier Reserves Released
InsuranceCarrierReservesReleased
5878000
ntra Insurance Carrier Reserves Released
InsuranceCarrierReservesReleased
8851000
CY2024Q3 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
15778000
CY2023Q3 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
16209000
CY2024Q3 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
13800000
ntra Noncash Operating Activities Related To Right Of Use Assets
NoncashOperatingActivitiesRelatedToRightOfUseAssets
38200000
ntra Noncash Operating Activities Related To Right Of Use Assets
NoncashOperatingActivitiesRelatedToRightOfUseAssets
100000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9762000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11621000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
98953000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
67025000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
108715000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
78646000
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.072
CY2024Q3 us-gaap Lease Cost
LeaseCost
4000000.0
CY2023Q3 us-gaap Lease Cost
LeaseCost
3600000
us-gaap Lease Cost
LeaseCost
11200000
us-gaap Lease Cost
LeaseCost
11000000.0
CY2024Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
4200000
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
3200000
us-gaap Operating Lease Payments
OperatingLeasePayments
12500000
us-gaap Operating Lease Payments
OperatingLeasePayments
8400000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4315000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
17391000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
17661000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
16997000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
17332000
CY2024Q3 ntra Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
70693000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
144389000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
35674000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
108715000
CY2024Q1 us-gaap Loss Contingency Patents Allegedly Infringed Number
LossContingencyPatentsAllegedlyInfringedNumber
2
CY2024Q1 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
57000000
CY2024Q3 us-gaap Purchase Obligation
PurchaseObligation
101046000
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
70644000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
57587000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
202502000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
142376000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
730000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
202000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2050000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
80000
CY2024Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22536000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22571000

Files In Submission

Name View Source Status
0001558370-24-015325-index-headers.html Edgar Link pending
0001558370-24-015325-index.html Edgar Link pending
0001558370-24-015325.txt Edgar Link pending
0001558370-24-015325-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ntra-20240930.xsd Edgar Link pending
ntra-20240930x10q.htm Edgar Link pending
ntra-20240930xex31d1.htm Edgar Link pending
ntra-20240930xex31d2.htm Edgar Link pending
ntra-20240930xex32d1.htm Edgar Link pending
ntra-20240930xex32d2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
ntra-20240930_cal.xml Edgar Link unprocessable
ntra-20240930_def.xml Edgar Link unprocessable
ntra-20240930x10q_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ntra-20240930_lab.xml Edgar Link unprocessable
ntra-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable